17. B. Braun Melsungen
Revenue: $8,363,373,220*
(€7,471,300,000)
Melsungen, Germany (U.S. HQ in Bethlehem, Pa.)
2019 rank: 17
R&D spend: $362,125,900
Employees: 64,000
*Fiscal year ended 12/31/2019
B. Braun offers roughly 5,000 products, most of them made by the company, covering a wide range of areas including infusion, nutrition and pain therapy, infusion pumps and systems, disinfection products, surgical instruments, suture materials, hip and knee implants, dialysis equipment, and accessories for extracorporeal blood treatment. There are also products for ostomy care, and diabetes and wound management. Regulatory wins this year include FDA clearance for the SpaceStation MRI to allow Space infusion pumps to continuously deliver medications to patients within the MRI suite. – CN
Key personnel: Anna Maria Braun, CEO; Jean-Claude Dubacher, CEO at B. Braun of America; Annette Beller, board member, finance, taxes & central services; Meinrad Lugan, board member, hospital care division, outpatient market division; Joachim Schulz, board member, Aesculap division; Markus Strotmann, board member, Avitum division